BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33751828)

  • 1. The NFIB-ERO1A axis promotes breast cancer metastatic colonization of disseminated tumour cells.
    Zilli F; Marques Ramos P; Auf der Maur P; Jehanno C; Sethi A; Coissieux MM; Eichlisberger T; Sauteur L; Rouchon A; Bonapace L; Pinto Couto J; Rad R; Jensen MR; Banfi A; Stadler MB; Bentires-Alj M
    EMBO Mol Med; 2021 Apr; 13(4):e13162. PubMed ID: 33751828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NFIB promotes cell survival by directly suppressing p21 transcription in TP53-mutated triple-negative breast cancer.
    Liu RZ; Vo TM; Jain S; Choi WS; Garcia E; Monckton EA; Mackey JR; Godbout R
    J Pathol; 2019 Feb; 247(2):186-198. PubMed ID: 30350349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NCOA1 promotes angiogenesis in breast tumors by simultaneously enhancing both HIF1α- and AP-1-mediated VEGFa transcription.
    Qin L; Xu Y; Xu Y; Ma G; Liao L; Wu Y; Li Y; Wang X; Wang X; Jiang J; Wang J; Xu J
    Oncotarget; 2015 Sep; 6(27):23890-904. PubMed ID: 26287601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer.
    Wu N; Jia D; Ibrahim AH; Bachurski CJ; Gronostajski RM; MacPherson D
    Oncotarget; 2016 Sep; 7(36):57514-57524. PubMed ID: 27613844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NFIB is a potential target for estrogen receptor-negative breast cancers.
    Moon HG; Hwang KT; Kim JA; Kim HS; Lee MJ; Jung EM; Ko E; Han W; Noh DY
    Mol Oncol; 2011 Dec; 5(6):538-44. PubMed ID: 21925980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small Cell Lung Cancer Plasticity Enables NFIB-Independent Metastasis.
    Ko JH; Lambert KE; Bhattacharya D; Lee MC; Colón CI; Hauser H; Sage J
    Cancer Res; 2024 Jan; 84(2):226-240. PubMed ID: 37963187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYB-NFIB gene fusion in adenoid cystic carcinoma of the breast with special focus paid to the solid variant with basaloid features.
    D'Alfonso TM; Mosquera JM; MacDonald TY; Padilla J; Liu YF; Rubin MA; Shin SJ
    Hum Pathol; 2014 Nov; 45(11):2270-80. PubMed ID: 25217885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of PPARδ Induces VEGFA-Mediated Angiogenesis
    Luo W; He D; Zhang J; Ma Z; Chen K; Lv Z; Fan C; Yang L; Li Y; Zhou Z
    Front Oncol; 2021; 11():713892. PubMed ID: 34712608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NFIB functions as an oncogene in estrogen receptor-positive breast cancer and is regulated by miR-205-5p.
    Chen H; Yu C; Shen L; Wu Y; Wu D; Wang Z; Song G; Chen L; Hong Y
    Pathol Res Pract; 2020 Dec; 216(12):153236. PubMed ID: 33038688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of MYB-NFIB chimeric gene expression, tumor angiogenesis, and proliferation in adenoid cystic carcinoma of salivary gland.
    Ono J; Okada Y
    Odontology; 2018 Jul; 106(3):238-244. PubMed ID: 29243184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NFIB promotes cell growth, aggressiveness, metastasis and EMT of gastric cancer through the Akt/Stat3 signaling pathway.
    Wu C; Zhu X; Liu W; Ruan T; Wan W; Tao K
    Oncol Rep; 2018 Sep; 40(3):1565-1573. PubMed ID: 30015981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circ_0069718 promotes the progression of breast cancer by up-regulating NFIB through sequestering miR-590-5p.
    Zhao Y; Ma X; Shi W
    Mamm Genome; 2021 Dec; 32(6):517-529. PubMed ID: 34632534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma.
    Yang B; Zhou ZH; Chen L; Cui X; Hou JY; Fan KJ; Han SH; Li P; Yi SQ; Liu Y
    Cancer Med; 2018 May; 7(5):1756-1765. PubMed ID: 29577671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-302a Inhibits Metastasis and Cetuximab Resistance in Colorectal Cancer by Targeting NFIB and CD44.
    Sun L; Fang Y; Wang X; Han Y; Du F; Li C; Hu H; Liu H; Liu Q; Wang J; Liang J; Chen P; Yang H; Nie Y; Wu K; Fan D; Coffey RJ; Lu Y; Zhao X; Wang X
    Theranostics; 2019; 9(26):8409-8425. PubMed ID: 31754405
    [No Abstract]   [Full Text] [Related]  

  • 15. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway.
    Zhang Q; Lu S; Li T; Yu L; Zhang Y; Zeng H; Qian X; Bi J; Lin Y
    J Exp Clin Cancer Res; 2019 Apr; 38(1):173. PubMed ID: 31023337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients.
    Semenova EA; Kwon MC; Monkhorst K; Song JY; Bhaskaran R; Krijgsman O; Kuilman T; Peters D; Buikhuisen WA; Smit EF; Pritchard C; Cozijnsen M; van der Vliet J; Zevenhoven J; Lambooij JP; Proost N; van Montfort E; Velds A; Huijbers IJ; Berns A
    Cell Rep; 2016 Jul; 16(3):631-43. PubMed ID: 27373156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells.
    Png KJ; Halberg N; Yoshida M; Tavazoie SF
    Nature; 2011 Dec; 481(7380):190-4. PubMed ID: 22170610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia induces miR-153 through the IRE1α-XBP1 pathway to fine tune the HIF1α/VEGFA axis in breast cancer angiogenesis.
    Liang H; Xiao J; Zhou Z; Wu J; Ge F; Li Z; Zhang H; Sun J; Li F; Liu R; Chen C
    Oncogene; 2018 Apr; 37(15):1961-1975. PubMed ID: 29367761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA expression profiles in metastatic and non-metastatic giant cell tumor of bone.
    Mosakhani N; Pazzaglia L; Benassi MS; Borze I; Quattrini I; Picci P; Knuutila S
    Histol Histopathol; 2013 May; 28(5):671-8. PubMed ID: 23172052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma.
    Mirabello L; Koster R; Moriarity BS; Spector LG; Meltzer PS; Gary J; Machiela MJ; Pankratz N; Panagiotou OA; Largaespada D; Wang Z; Gastier-Foster JM; Gorlick R; Khanna C; de Toledo SR; Petrilli AS; Patiño-Garcia A; Sierrasesúmaga L; Lecanda F; Andrulis IL; Wunder JS; Gokgoz N; Serra M; Hattinger C; Picci P; Scotlandi K; Flanagan AM; Tirabosco R; Amary MF; Halai D; Ballinger ML; Thomas DM; Davis S; Barkauskas DA; Marina N; Helman L; Otto GM; Becklin KL; Wolf NK; Weg MT; Tucker M; Wacholder S; Fraumeni JF; Caporaso NE; Boland JF; Hicks BD; Vogt A; Burdett L; Yeager M; Hoover RN; Chanock SJ; Savage SA
    Cancer Discov; 2015 Sep; 5(9):920-31. PubMed ID: 26084801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.